Skip to content

Clinical trials

Fragile X Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fragile X Syndrome Country / region: United States Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20061
20072
20083
20098
20104
20118
20125
20133
20142
20151
20166
20172
20188
20191
20202
20214
20227
20234
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting7
Terminated6
Active, not recruiting5
Unknown status5
Withdrawn3
Enrolling by invitation2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seaside Therapeutics, Inc.9
Children's Hospital Medical Center, Cincinnati8
Stanford University7
University of California, Davis6
Novartis Pharmaceuticals5
Tetra Discovery Partners4
Hoffmann-La Roche3
Indiana University3
RTI International3
Elizabeth Berry-Kravis2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fragile X Syndrome81
Autism Spectrum Disorder13
Genetic Diseases, Inborn8
Intellectual Disability7
Autistic Disorder6
Developmental Disabilities5
Down Syndrome5
Angelman Syndrome4
Neurodevelopmental Disorders3
Prader-Willi Syndrome3

Trials

Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.